United States

People: Progressive Corp (PGR.N)

PGR.N on New York Stock Exchange

22 Sep 2017
Change (% chg)

$0.30 (+0.63%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Sheares, Bradley 

Dr. Bradley T. Sheares, Ph.D. is no longer as Independent Director of The Progressive Corporation, effective May 2018. He is Corporate Director; Former Chief Executive Officer, Reliant Pharmaceuticals, Inc., Liberty Corner, New Jersey (pharmaceutical products). Dr. Sheares has substantial executive management experience he attained in his tenure as President of the U.S. Human Health Division of Merck & Co., Inc. and as Chief Executive Officer of Reliant Pharmaceuticals, Inc. These roles enabled Dr. Sheares to gain valuable sales, marketing, advertising, brand management, healthcare, mergers and acquisitions, research and development, and risk management experience. The Board also benefits from the technical perspective Dr. Sheares brings, due in part to his having earned a Ph.D. in biochemistry and his background in the sciences. In addition, the Board values the significant experience Dr. Sheares has gained through his service on the boards of a diverse set of public companies.

Basic Compensation

Total Annual Compensation, USD 110,000
Restricted Stock Awards, USD 165,003
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 275,003

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Glenn Renwick


Susan Griffith


John Sauerland


John Auer


John Barbagallo


Patrick Callahan

As Of  30 Dec 2016